Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Other Operating Expenses (2018 - 2025)

Volitionrx filings provide 9 years of Other Operating Expenses readings, the most recent being $1499.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 4044.74% to $1499.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $919128.0, a 43.89% decrease, with the full-year FY2025 number at $1829.0, up 105.27% from a year prior.
  • Other Operating Expenses hit $1499.0 in Q4 2025 for Volitionrx, up from $330.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.8 million in Q4 2021 to a low of -$33498.0 in Q2 2024.
  • Median Other Operating Expenses over the past 5 years was $494657.0 (2021), compared with a mean of $704064.8.
  • Biggest five-year swings in Other Operating Expenses: tumbled 154.29% in 2024 and later surged 4044.74% in 2025.
  • Volitionrx's Other Operating Expenses stood at $1.8 million in 2021, then fell by 2.38% to $1.8 million in 2022, then tumbled by 100.0% to $70.0 in 2023, then tumbled by 154.29% to -$38.0 in 2024, then surged by 4044.74% to $1499.0 in 2025.
  • The last three reported values for Other Operating Expenses were $1499.0 (Q4 2025), $330.0 (Q2 2025), and $917299.0 (Q1 2025) per Business Quant data.